A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma

Teis Esben Søndergaard, PT Pedersen, Thomas Levin Andersen, K Søe, T Lund, B Ostergaard, P Garnero, Jean-Marie Delaissé, T Plesner

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Udgivelsesdato: Jul-31
OriginalsprogEngelsk
TidsskriftHematological Oncology
ISSN0278-0232
DOI
StatusUdgivet - 31. jul. 2008

Fingeraftryk

Dyk ned i forskningsemnerne om 'A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma'. Sammen danner de et unikt fingeraftryk.

Citationsformater